BiomX Inc. earnings releases HLSQ

BiomX Inc. last reported quarterly results on Nov 12, 2025, for Q3 FY2025 (the quarter ended Sep 30, 2025): diluted EPS of $0.29. It usually reports 43–45 days after a quarter ends.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 43–45 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Nov 12, 2025
43 days after quarter end
Q3 FY2025
ended Sep 30, 2025
—
-9
-195.1%
0.29
+193.5%
Aug 13, 2025
44 days after quarter end
Q2 FY2025
ended Jun 30, 2025
—
-6
-235.0%
3.66
+430.4%
May 15, 2025
45 days after quarter end
Q1 FY2025
ended Mar 31, 2025
—
-8
+55.8%
6.27
+125.5%
Nov 14, 2024
45 days after quarter end
Q3 FY2024
ended Sep 30, 2024
—
10
+222.0%
-0.31
-123.8%
Apr 3, 2024
3 days after quarter end
—
ended Mar 31, 2024
—
—
—
Nov 14, 2023
45 days after quarter end
—
ended Sep 30, 2023
—
—
—
Aug 9, 2023
40 days after quarter end
—
ended Jun 30, 2023
—
—
—
May 15, 2023
45 days after quarter end
—
ended Mar 31, 2023
—
—
—

Company profile

Industry
Services-Prepackaged Software (SIC 7372)
Listed as
HLSQ (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Dover, DE
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1739174
Former names
BiomX Inc. (until Sep 9, 2026); Chardan Healthcare Acquisition Corp. (until Oct 23, 2019)

Other Services-Prepackaged Software companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.